An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse

Anecdotal and scientific evidence suggests that Cannabis use may be beneficial in inflammatory bowel disease (IBD) patients. Here, we have investigated the effect of a standardized Cannabis sativa extract with high content of cannabidiol (CBD), here named CBD BDS for “CBD botanical drug substance,”...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Pharmacol
Päätekijät: Pagano, Ester, Capasso, Raffaele, Piscitelli, Fabiana, Romano, Barbara, Parisi, Olga A., Finizio, Stefania, Lauritano, Anna, Marzo, Vincenzo Di, Izzo, Angelo A., Borrelli, Francesca
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2016
Aiheet:
Pharmacology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5047908/
https://ncbi.nlm.nih.gov/pubmed/27757083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00341
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia